Posts Tagged ‘biotech’

  I’m not going to get into whether prescribing or using drugs for off-label purposes makes sense – you can decide that for yourself. However, what I will tell you is that it’s a hot topic in the industry right now. Pharmaceutical companies continue to lobby the FDA to eliminate any prohibition of off-label promotion […]

  It’s not in the San Francisco Bay Area or San Diego. Nor is it in North Carolina or Seattle. 

  Welcome to the first post in the 21 CFR Part 11 “mini-series” focused on Subpart C – Electronic Signatures. We’ve come a long way since that first post in which we decoded what the name “21 CFR Part 11” even means, haven’t we? We are in the final stretch! Let’s get out our decoder […]

  When Hurricane Sandy struck the U.S. in 2012, it was devastating, to say the least. It damaged homes, businesses, and schools. No one in its path was left untouched. Even data centers were flooded and left without power, taking critical systems offline. Experiences like Sandy make you wish you had a plan in place […]

  Earlier this week, The Wall Street Journal published an article on some issues that companies encounter when running their systems in the cloud. It points out that a considerable amount of money is wasted on resources such as unused power or even servers. That’s not a surprise. If you don’t know what you’re doing, mistakes […]

Here in Perficient’s life sciences practice, we use a defect tracking system as part of our application development process. It helps us keep track of bugs and resolutions as we develop and test, but there’s nothing particularly remarkable about it…except that we use it for another purpose too: to track problems with our QA controlled […]

Pretty bad and pretty funny. That’s how I’d summarize what the websites looked like for these 13 biopharma, medical device, and research organizations when they first made their mark on the World Wide Web. In honor of Throwback Thursday, we used Internet Archive’s Wayback Machine to poke fun at the companies many of us have come to […]

Just kidding. You may have read the story on TMZ of a New York businessman making big bucks off the panic surrounding Ebola. Guess what? The FDA hit him where it hurts. His site is down. Stop trying to trick the public. Stop being sleazy. That’s the message the FDA is sending to pharmaceutical, medical […]

It’s no secret that validation can be a bear. All of that documentation and testing, the multiple phases with pesky transition gates, a million reviews and approvals…it can really slow down an IT project, which often leads to questions about why on Earth we bother with it. Well, it all traces back to rules and regulations […]

The other day, I was watching Cory Johnson interview Bryson Koehler, CTO and CIO of The Weather Company, on Bloomberg West. While the talk focused on The Weather Company’s business model, I thought several points during the discussion were quite relevant to life sciences companies. Frankly, they’re applicable to most industries. The Weather Channel, which […]

We’re all users of software. Put us in front of two systems – one that looks outdated and unorganized, and one that looks good and structurally makes sense – and I bet you’d gravitate to the latter one. In fact, although I didn’t conduct a poll, I’m sure we’d all choose the latter. It’s not […]

I recently heard a segment on the radio about personalized medicine. Or “translational medicine.” Or “translational research.” Or “precision medicine.” Whatever you want to call it! Dr. Murray Feingold, a pediatrician and geneticist in the Boston area, painted a clear description of the term. He put it in words that all of us can understand. […]